These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20938933)

  • 1. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening.
    Kawaguchi M; Okabe T; Terai T; Hanaoka K; Kojima H; Minegishi I; Nagano T
    Chemistry; 2010 Dec; 16(45):13479-86. PubMed ID: 20938933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase-4 inhibitor with β-amino amide scaffold: synthesis, SAR and biological evaluation.
    Kim HJ; Kwak WY; Min JP; Sung SY; Kim HD; Kim MK; Kim HS; Park KJ; Son MH; Kim SH; Lee BJ
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5545-9. PubMed ID: 22850208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitors.
    Zhu L; Li Y; Qiu L; Su M; Wang X; Xia C; Qu Y; Li J; Li J; Xiong B; Shen J
    ChemMedChem; 2013 Jul; 8(7):1104-16. PubMed ID: 23671024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations.
    Li C; Shen J; Li W; Lu C; Liu G; Tang Y
    Proteins; 2011 Jun; 79(6):1800-9. PubMed ID: 21465558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H
    Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
    Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
    Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of a dipeptide library for inhibitor development using human dipeptidyl peptidase IV produced by a Saccharomyces cerevisiae expression system.
    Hikida A; Ito K; Motoyama T; Kato R; Kawarasaki Y
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1217-22. PubMed ID: 23268343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes.
    Brigance RP; Meng W; Fura A; Harrity T; Wang A; Zahler R; Kirby MS; Hamann LG
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4395-8. PubMed ID: 20598534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicyclic cyanothiazolidines as novel dipeptidyl peptidase 4 inhibitors.
    Betancort JM; Winn DT; Liu R; Xu Q; Liu J; Liao W; Chen SH; Carney D; Hanway D; Schmeits J; Li X; Gordon E; Campbell DA
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4437-40. PubMed ID: 19482472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
    Kim MK; Chae YN; Kim HD; Yang EK; Cho EJ; Choi SH; Cheong YH; Kim HS; Kim HJ; Jo YW; Son MH; Kim SH; Shin CY
    Life Sci; 2012 Jan; 90(1-2):21-9. PubMed ID: 22056373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.
    Rea D; Van Elzen R; De Winter H; Van Goethem S; Landuyt B; Luyten W; Schoofs L; Van Der Veken P; Augustyns K; De Meester I; Fülöp V; Lambeir AM
    Eur J Med Chem; 2017 Oct; 139():482-491. PubMed ID: 28826083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of sitagliptin on collagen-derived dipeptides in diabetic osteoporosis.
    Baerts L; Glorie L; Maho W; Eelen A; Verhulst A; D'Haese P; Covaci A; De Meester I
    Pharmacol Res; 2015 Oct; 100():336-40. PubMed ID: 26342756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.
    Nishio Y; Kimura H; Tosaki S; Sugaru E; Sakai M; Horiguchi M; Masui Y; Ono M; Nakagawa T; Nakahira H
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7246-9. PubMed ID: 21074430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors.
    Matheeussen V; Lambeir AM; Jungraithmayr W; Gomez N; Mc Entee K; Van der Veken P; Scharpé S; De Meester I
    Clin Chim Acta; 2012 Feb; 413(3-4):456-62. PubMed ID: 22093941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors].
    Han B; Huan Y; Lin ZY; Li P; Shen ZF; Yin DL; Huang HH
    Yao Xue Xue Bao; 2010 Nov; 45(11):1379-84. PubMed ID: 21361038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization.
    Zeng S; Xie H; Zeng LL; Lu X; Zhao X; Zhang GC; Tu ZC; Xu HJ; Yang L; Zhang XQ; Hu W
    Bioorg Med Chem; 2013 Apr; 21(7):1749-55. PubMed ID: 23434133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Xia C; Wang J; Su M; Zhang L; Dong T; Li Z; Wan X; Li J; Li J; Zhao L; Gao Z; Jiang H; Liu H
    Eur J Med Chem; 2014 Oct; 86():242-56. PubMed ID: 25164763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma.
    Jost MM; Lamerz J; Tammen H; Menzel C; De Meester I; Lambeir AM; Augustyns K; Scharpé S; Zucht HD; Rose H; Jürgens M; Schulz-Knappe P; Budde P
    Biochem Pharmacol; 2009 Jan; 77(2):228-37. PubMed ID: 18940185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
    Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J
    Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
    Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
    Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.